Analysis / Anduril · Hiive
AI Analysis
Anduril · Hiive
Share price $29.40 · Implied valuation $14.7B · SPV
Investment Score
73
/ 100
Hold
Executive Summary
Anduril secondary via Hiive at $29.40/share implies a +5.0% mark vs the last primary round of $14.0B. All-in cost load of ~10.0% must be earned back before any IPO upside.
Implied Val
$14.7B
Min Check
$50K
Fees
5%
Carry
20%
Valuation Analysis
Implied valuation $14.7B vs last round $14.0B (premium of 5.0%). Tape across other platforms ranges $27.17–$30.03.
Fee Analysis
5% upfront fee plus 20% carry on profits. Structure: SPV. Effective hurdle: investors need ~12.0% appreciation before breakeven on cost basis.
Risk Factors
- 01SPV stacking — you own LP interest, not shares.
- 02Information asymmetry: limited visibility into Anduril's 2024 revenue and burn.
- 03Liquidity: no defined exit window; IPO timing uncertain.
- 04Carry above 12.5% materially compresses net returns at modest exit multiples.
Upside Scenarios
- 01IPO at 1.8–2.5x last round implies $59+/share gross.
- 02Defense Tech comps trading at premium multiples support re-rating.
- 03Tender offers in next 12 months could provide partial liquidity.
Downside Scenarios
- 01Down-round risk if macro tightens or growth decelerates.
- 02Fee drag of ~10.0% wipes out modest 1.2–1.4x exits.
- 03Lockup or ROFR could delay realization 12–24 months post-IPO.
Questions to Ask the Seller
- 01What is the actual underlying share class (common vs preferred series)?
- 02Are there transfer restrictions or company ROFR on this lot?
- 03What does the cap table look like post-dilution from the most recent round?
- 04Can the seller provide the most recent 409A or audited financials?
- 05What is the SPV's management fee structure and dissolution waterfall?
AI Recommendation
Hold
Independent of any platform. Not investment advice — use as one input alongside your own diligence.